Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biocon Pharma is a subsidiary of Biocon Limited, dedicated to the development and manufacture of generic finished dosage formulations for global markets. The company focuses on complex oral solid dosage forms, including potent compounds and modified-release formulations. By leveraging the parent company's strong foundation in active pharmaceutical ingredients (APIs), Biocon Pharma maintains a vertically integrated business model that ensures high quality and cost-efficiency. Its product portfolio targets chronic disease areas such as cardiovascular health, oncology, and immunology. The company operates state-of-the-art manufacturing facilities in Bengaluru, India, which are regularly inspected and approved by the US FDA and other international regulatory bodies. Biocon Pharma plays a strategic role in expanding Biocon's global footprint by providing affordable generic alternatives to essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biocon Pharma.